期刊文献+

戒烟门诊强化心理行为干预的临床戒烟效果 被引量:6

The evaluation of strengthened psychological and behavioral intervention in smoking cessation clinics
原文传递
导出
摘要 目的 探讨戒烟门诊应用伐尼克兰联合强化心理行为干预的临床戒烟效果以及分析戒烟成功预测指标.方法 将2009年3月至2010年9月复旦大学附属中山医院“吸烟及其相关疾病门诊”进行戒烟咨询和干预者作为研究对象,筛选合适对象,分为加强随访组和普通随访组,主要观察第9~12周持续戒断率,应用logistic回归模型进行戒烟成功预测指标分析.结果 戒烟门诊烟草依赖患者应用伐尼克兰联合强化干预治疗第9~12周持续总体戒断率为52.3%,加强随访组60.9% (28/46),普通随访组46.2% (30/65),主要不良反应为恶心(39.6%,44/111),睡眠差和梦境异常(17.1%,19/111),均可耐受,戒断症状少.戒烟准备程度和服药时间可作为戒烟成功预测指标.结论 伐尼克兰联合心理行为干预临床戒断率高,强化心理行为干预更明显增加成功率,是戒烟门诊很好的治疗方案,充分戒烟准备和规律足疗程服药能进一步提高戒烟成功率. Objective To evaluate the effect of psychological and behavioral intervention combined with varenicline smoking cessation clinics and to analyze predictors of successful quitting.Methods Subjects were collected from quitters who went to receive consultation and intervention in “smoking and related diseases” clinic at Zhongshan Hospital,Fudan University from March 2009 to September 2010.Eligible subjects were screened and divided into strengthen follow-up group and control group.The 4 weeks continuous abstinence rate from week 9 through week 12 were observed logistic regression model and used to analyze the predictors of successful quitting.Results Subjects who are addicted to nicotine received strengthening psychological and behavioral intervention combined with varenicline in smoking cessation clinics.The total continuous cessation rate during the 9th-12th week was 52.3%,with 60.9% (28/46) and 46.2% (30/65) of strengthen follow-up group and control group respectively.The most frequent adverse effects were nausea 39.6% (44/111),insomnia and abnormal dreams 17.1% ( 19/111 ).Adverse effects were tolerable and withdraw symptoms were few.Preparation and medication time can be used as predictors of successful quitting.Conclusion The quit rate of varenicline therapy combining with strengthen intervention is high and strengthening psychological and behavioral intervention could increase the success rate more obviously,which is a good choice for cessation therapy in smoking cessation clinics.Better preparation and regular adequate treatment can improve quit rate.
出处 《中华内科杂志》 CAS CSCD 北大核心 2011年第12期1019-1022,共4页 Chinese Journal of Internal Medicine
基金 中华医学基金会(09-960) 上海市重点学科建设项目(B115)
关键词 戒烟 治疗结果 伐尼克兰 强化心理行为干预 Smoking cessation Treatment outcome Varenicline Strengthening psychological and behavioral intervention
  • 相关文献

参考文献23

  • 1杨功焕,马杰民,刘娜,周灵妮.中国人群2002年吸烟和被动吸烟的现状调查[J].中华流行病学杂志,2005,26(2):77-83. 被引量:1054
  • 2Hu TW,Mao Z,Ong M,et al.China at the crossroads:the economics of tobacco and health.Tob Control,2006,15 Suppl 1:i37-41. 被引量:1
  • 3马冠生,孔灵芝,栾德春,李艳平,胡小琪,王京钟,杨晓光.中国居民吸烟行为的现状分析[J].中国慢性病预防与控制,2005,13(5):195-199. 被引量:250
  • 4Coe JW,Brooks PR,Wirtz MC,et al.3,5-Bicyclic aryl piperidines:a novel class of alpha4beta2 neuronal nicotinic receptor partial agonists for smoking cessation.Bioorg Med Chem Lett,2005,15:4889-4897. 被引量:1
  • 5Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel,Liaisons,and Staff.A clinical practice guideline for treating tobacco use and dependence:2008 update.A U.S.Public Health Service report.Am J Prey Med,2008,35:158-176. 被引量:1
  • 6Jorenby DE,Hays JT,Rigotti NA,et al.Efficacy of varenicline,an alpha4beta2 nicotinic acetylcholine receptor partial agonist,vs placebo or sustained-release bupropion for smoking cessation:a randomized controlled trial.JAMA,2006,296:56-63. 被引量:1
  • 7Fu SS,Partin MR,Snyder A,et al.Promoting repeat tobacco dependence treatment:are relapsed smokers interested? Am J Manag Care,2006,12:235-243. 被引量:1
  • 8Hammond D,McDonald PW,Fong GT,et aL Do smokers know how to quit? Knowledge and perceived effectiveness of cessation assistance as predictors of cessation behaviour.Addiction,2004,99:1042-1048. 被引量:1
  • 9Gonzales D,Rennard SI,Nides M,et al.Varenicline,an alpha4beta2 nicotinic acetylcholine receptor partial agonist,vs sustained-release bupropion and placebo for smoking cessation:a randomized controlled trial.JAMA,2006,296:47-55. 被引量:1
  • 10Aubin HJ,Bobak A,Britton JR,et al.Varenicline versus transdermal nicotine patch for smoking cessation:results from a randomised open-label trial.Thorax,2008,63:717-724. 被引量:1

二级参考文献39

  • 1杨功焕,马杰民,刘娜,周灵妮.中国人群2002年吸烟和被动吸烟的现状调查[J].中华流行病学杂志,2005,26(2):77-83. 被引量:1054
  • 2杨晓光,孔灵芝,翟凤英,马冠生,金水高,中国居民营养与健康状况调查技术执行组.中国居民营养与健康状况调查的总体方案[J].中华流行病学杂志,2005,26(7):471-474. 被引量:174
  • 3朴建华,张坚,赵文华,由悦,杨晓光,中国居民营养与健康状况调查技术执行组.中国居民营养与健康状况调查的质量控制[J].中华流行病学杂志,2005,26(7):474-477. 被引量:54
  • 4中国预防医学科学院.1996年全国吸烟行为的流行病学调查[M].北京:中国科学技术出版社,1997.16. 被引量:37
  • 5Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study) : case-control study. Lancet, 2004,364:937-952. 被引量:1
  • 6Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA,2003,290 : 86-97. 被引量:1
  • 7Wu P, Wilson K, Dimoulas P, et al. Effectiveness of smoking cessation therapies: a systematic review and meta-analysis. BMC Public Health ,2006,6:300. 被引量:1
  • 8Huang CL, Lin HH, Wang HH. Evaluating screening performances of the Fagerstrom tolerance questionnaire, the Fagerstrom test for nicotine dependence and the heavy smoking index among Taiwan Residents male smokers. J Clin Nurs, 2008,17:884- 890. 被引量:1
  • 9Lavi S, Prasad A, Yang EH, et al. Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease. Circulation, 2007,115:2621-2627. 被引量:1
  • 10Teo KK, Ounpuu S, Hawken S, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet,2006,368:647-658. 被引量:1

共引文献1314

同被引文献66

  • 1周胜亮,许萍,李平,胡招娣,徐春燕,王键键.伐尼克兰戒烟治疗对老年男性气道阻力的影响[J].中国老年学杂志,2014,34(11):3015-3017. 被引量:2
  • 2傅鹰.药物戒烟的循证性临床指南综述[J].中国药物依赖性杂志,2005,14(2):136-140. 被引量:5
  • 3周培岚,苏瑞斌.大麻素CB1受体对条件性药物渴求的控制作用[J].国外医学(药学分册),2006,33(4):294-296. 被引量:3
  • 4World Health Organization. WHO report on the global to- bacco epidemic 2008: The MPOWER package[R]. Gene- va: World Health Organization, 2008. 被引量:1
  • 5Critchley JA, Capewell S.Mortality risk reduction associat- ed with smoking cessation in patients with coronary heart disease: a systematic review[J].JAMA, 2003,290( 1 ) : 86. 被引量:1
  • 6Coe JW, Brooks PR, Veteiino MG, et al.Varenieiine: an al- pha4beta2 nicotinic receptor partial agonist for smoking cessation[J].Med Chern, 2005,48 (10) : 3 474. 被引量:1
  • 7Liu BQ, Peto R, Chen ZM, et al. Emerging tobacco haz- ards in China: Retrospective proportional mortality study of one million deaths[J].Br Med J, 1998,317 ( ? 170 ) : 1411. 被引量:1
  • 8王辰,肖丹,孙永昌,等.中国临床戒烟指南:试行本[M].2007版.北京:人民卫生出版社,2007:7. 被引量:1
  • 9Gonzales D, Rennard SI, Nides M, et al. Varenicline, analpha4beta2 nicotinic acetylcholine receptor partial ago- nist, vs sustained-release bupropion and placebo for sm- oking cessation: A randomized controlled trial[J].JAMA,2006, 296(1):47. 被引量:1
  • 10Aubin H J, Bobak A, Britton JR, et al.Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial[J]. Thorax, 2008, 63 (8):717. 被引量:1

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部